india glp-1 Since the patent for semaglutide, the key ingredient in weight loss drugs, expired in March, prices in have fallen 80%. The country's market has expanded by a factor of ten in just one Inside OneSource: India’s Next Big

The North America obesity GLP-1 market size is estimated at USD 4.93 billion in 2025 and is projected to reach approximately USD 40.27 billion by 2035, with a 23.37% CAGR from 2026 to 2035

The fact that there's a medically approved prescription for managing weight and staying healthier, in my lifetime, feels like relief, like redemption, like a gift, and not something to hide behind and once again be ridiculed for

Nadolsky and asked if he was hiring dietitians

The dosing guidance was clear

Like other GLP-1 receptor agonists, Exenatide extended release, sold as Bydureon BCise, works by mimicking the action of the natural hormone GLP-1

The Medicare GLP1 Bridge program Starting July 1, 2026, the Medicare GLP1 Bridge provides coverage for GLP1 weight-loss medications for the first time under a temporary demonstration program